Burden and Healthcare Needs of Caregivers of Children with Inflammatory Bowel Disease after the End of China’s Dynamic Zero-COVID-19 Policy: A Single Center Study
Published: 2024-05-22
Page: 112-127
Issue: 2024 - Volume 7 [Issue 1]
Yiwen Zhou *
Department of Gastroenterology and Hepatology, Children’s Hospital of Fudan University, Shanghai, China.
Xiaofeng Xu
Department of Gastroenterology and Hepatology, Children’s Hospital of Fudan University, Shanghai, China.
Yuyan Huang
Department of Gastroenterology and Hepatology, Children’s Hospital of Fudan University, Shanghai, China.
Ying Gu
Nursing Department, Children’s Hospital of Fudan University, Shanghai, China.
Zhaoyang Gou
Department of Gastroenterology and Hepatology, Children’s Hospital of Fudan University, Shanghai, China.
Zhuowen Yu
Department of Gastroenterology and Hepatology, Children’s Hospital of Fudan University, Shanghai, China.
*Author to whom correspondence should be addressed.
Abstract
Background: Following China's decision to end its dynamic Zero-COVID-19 Policy in December 2022, COVID-19 infections surged in the subsequent month. Presently, there exists a scarcity of epidemiological data regarding COVID-19 in Chinese children with inflammatory bowel disease (IBD). Additionally, there is a lack of information regarding the burden of caregivers of these children and the specific healthcare requirements for home care.
Methods: From January 18 to February 1, 2023, an anonymous online survey was conducted to gather data on the demographics of participants, their experiences with COVID-19 infection, caregiver burden, and the healthcare needs of children with IBD.
Results: The study obtained a response rate of 73.06% from participants, consisting of 98 (54.75%) males and 81 (45.25%) females. The average age (SD) of the respondents was 11.44 (4.29) years old. Among the 179 children with IBD, 116 (64.80%) experienced COVID-19 infection.
Caregivers reported facing various burdens, with financial burdens being the most significant, followed by psychological, physical, and time burdens. Overall, caregivers of COVID-19-uninfected children experienced a heavier burden compared to those with COVID-19-infected children. Significant differences were observed in terms of physical burden (P=0.01) and time burden (P=0.03) between caregivers of COVID-19-infected and uninfected children.
The most needed health service for caregivers was found to be telemedicine service (Mean=3.66), followed by knowledge concerning COVID-19 in children with IBD (Mean=3.55), vaccination recommendations (Mean=3.40), diet and nutrition care (Mean=3.37), psychological counseling and care (Mean=2.51), care for perianal lesions (Mean=2.09), and care for wounds or stomas (Mean=1.84). However, there were no significant differences in healthcare needs between caregivers of COVID-19-infected and uninfected children.
Conclusions: In this study, despite more than half of the children being infected with COVID-19, the symptoms were mostly moderate, with no severe cases observed. Caregivers identified financial burden as the primary challenge, with caregivers of non-infected children experiencing a greater burden than those of infected children. There was a significant demand for telehealth services, highlighting the need for further development in China to meet the increasing medical care requirements during the pandemic.
Keywords: COVID-19, economic challenges, quarantine, potential human rights
How to Cite
References
World Health Organization. WHO Health Emergency Dashboard WHO (COVID-19) Homepage; 2023. Available:https://covid19.who.int/region/wpro/country/cn (Accessed March 05, 2023).
Cheng ZJ, Zhan Z, Xue M, et al. Public Health Measures and the Control of COVID-19 in China. Clin Rev Allergy Immunol. 2023;64(1):1-16. DOI: 10.1007/s12016-021-08900-2
Wilson O, Flahault A. China's U-turn in its COVID-19 policy. Anaesth Crit Care Pain Med. 2023;42(2):101197. DOI: 10.1016/j.accpm.2023.101197
Chen H, Shi L, Zhang Y, Wang X, Sun G. A cross-country core strategy comparison in China, Japan, Singapore and South Korea during the early COVID-19 pandemic. Glob Health. 2021;17:1–10. DOI: 10.1186/s12992-021-00672-w
Zheng W, Yan X, Zhao Z, Yang J, Yu H. COVID-19 vaccination program in the mainland of China: A subnational descriptive analysis on target population size and current progress. Infect Dis Poverty. 2021;10(1):124. DOI: 10.1186/s40249-021-00909-1
Tripathi K, Godoy Brewer G, Thu Nguyen M, Singh Y, Saleh Ismail M, Sauk JS, et al. COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2022;28(8):1265-1279. DOI: 10.1093/ibd/izab236
Surveillance Epidemiology of Coronavirus (COVID-19) Under Research Exclusion; 2023. Available:https://covidibd.org/current-data/ (Accessed March 05, 2023).
Brenner EJ, Ungaro RC, Gearry RB, et al. Corticosteroids, but not tnf antagonists, are associated with adverse covid-19 outcomes in patients with inflammatory Bowel Diseases: Results from an international registry. Gastroenterology. 2020;159(2):481-491.e3. DOI: 10.1053/j.gastro.2020.05.032
An P, Ji M, Ren H, Su J, Kang J, Yin A, et al. Protection of 318 inflammatory bowel disease patients from the outbreak and rapid spread of COVID-19 infection in Wuhan, China. Lancet; 2020. Available:https://ssrn.com/abstract=3543590.
An P, Ji M, Ren H, Su J, Ding NS, Kang J, et al. Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China. Lancet Gastroenterol Hepatol. 2020; 5(6):525-527. DOI: 10.1016/S2468-1253(20)30121-7
Amiot A, Rahier JF, Baert F, et al. The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study [published correction appears in J Crohns Colitis. 2023 Feb 18;:]. J Crohns Colitis. 2023;17(1):37-48. DOI: 10.1093/ecco-jcc/jjac091
Park CL, Russell BS, Fendrich M, Finkelstein-Fox L, Hutchison M, Becker J. Americans' COVID-19 Stress, Coping, and Adherence to CDC Guidelines. J Gen Intern Med. 2020 35(8):2296-2303. DOI: 10.1007/s11606-020-05898-9
Russell BS, Hutchison M, Tambling R, Tomkunas AJ, Horton AL. Initial Challenges of Caregiving During COVID-19: Caregiver Burden, Mental Health, and the Parent-Child Relationship. Child Psychiatry Hum Dev. 2020;51(5):671-682. DOI: 10.1007/s10578-020-01037-x
Dorfman L, Nassar R, Binjamin Ohana D, Oseran I, Matar M, Shamir R, et al. Pediatric inflammatory bowel disease and the effect of COVID-19 pandemic on treatment adherence and patients' behavior. Pediatr Res. 2021;90(3):637-641. DOI: 10.1038/s41390-020-01312-6.
Abraham B.P., Kahn S.A. Transition of Care in Inflammatory Bowel Disease. Gastroenterol. Hepatol. 2014;10:633–640.
Available:https://www.flexjobs.com/blog/post/flexjobs-survey-flexibility-support-parents-pandemic/
Batsiou A, Mantzios P, Piovani D, Tsantes AG, Kopanou Taliaka P, Liakou P, et al. SARS-CoV-2 infection and outcomes in children with inflammatory bowel diseases: A Systematic Review. J Clin Med. 2022; 11(23):7238. DOI: 10.3390/jcm11237238
COVID-19 Coronavirus Pandemic: Reported Cases and Deaths by Country or Territory. Available:https://www.worldometers.info/coronavirus/#countries (Accessed on March 05, 2023).
Abbas K, Procter SR, van Zandvoort K, Clark A, Funk S, Mengistu T, et al. Routine Childhood Immunisation During the COVID-19 Pandemic in Africa: A Benefit–Risk Analysis of Health Benefits Versus Excess Risk of SARS-CoV-2 Infection. Lancet Global Health. 2020;8(10):e1264–72. DOI: 10.1016/s2214-109x(20)30308-9
Zheng, Caifang; Shao, Weihao; Chen, Xiaorui; Zhang, Bowen; Wang, Gaili; Zhang, Weidong (). "Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis". International Journal of Infectious Diseases. 2022;114:252–260. doi: 10.1016/j.ijid.2021.11.009. PMC 8595975.
Zhang M. COVID-19 Vaccination Free to Chinese Residents: Official. Available:http://www.ecns.cn/news/2021-01-09/detail-ihafqmaz1834647.shtml (Accessed on 15 November 2022).
Zheng W, Yan X, Zhao Z, Yang J, Yu H. COVID-19 vaccination program in the mainland of China: A subnational descriptive analysis on target population size and current progress. Infect Dis Poverty. 2021;10(1):124. Published 2021 Oct 15. doi:10.1186/s40249-021-00909-1.
Wu J, Li Q, Silver Tarimo C, et al. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study. Front Immunol. 2021;12:781161. DOI: 10.3389/fimmu.2021.781161
Wang C, Han B, Zhao T, et al. Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study. Vaccine. 2021; 39(21):2833-2842. DOI: 10.1016/j.vaccine.2021.04.020
Wu X, Lin J, Buch H, et al. The COVID-19 vaccination hesitancy among the people with inflammatory bowel disease in China: A questionnaire study. Front Public Health. 2021;9:731578. DOI: 10.3389/fpubh.2021.731578
Doherty J, Fennessy S, Stack R, et al. Review Article: Vaccination for patients with inflammatory bowel disease during the COVID-19 pandemic. Aliment Pharmacol Ther. 2021;54(9):1110-1123. DOI: 10.1111/apt.16590.
Lev-Tzion R, Focht G, Lujan R, et al. COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation. Clin Gastroenterol Hepatol. 2022;20(6): e1263-e1282. DOI: 10.1016/j.cgh.2021.12.026.
Card TR, Nakafero G, Grainge MJ, et al. Is Vaccination Against COVID-19 Associated With Inflammatory Bowel Disease Flare? Self-Controlled Case Series Analysis Using the UK CPRD Am J Gastroenterol. 2023;10.14309/ajg.0000000000002205. DOI: 10.14309/ajg.000000000000220 [Accessed on2023 Feb 22].
Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, et al. Impact of SARS-CoV-2 vaccination on inflammatory bowel disease activity and development of vaccine-related adverse events: Results From PREVENT-COVID. Inflamm. Bowel Dis. 2021:izab302. DOI: 10.1093/ibd/izab302
Lev-Tzion R, Focht G, Lujan R, Mendelovici A, Friss C, Greenfeld S, Kariv R, Ben-Tov A, Matz E, Nevo D, et al. COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation. Clin. Gastroenterol. Hepatol. 2021;20: e1263–e1282. DOI: 10.1016/j.cgh.2021.12.026
Coffey JS. Parenting a child with chronic illness: A metasynthesis. Pediatr Nurs. 2006;32(1):51-9.
Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39:355–368.
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of covid-19 patients with digestive symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am J Gastroenterol. 2020;115(5):766-773. DOI: 10.14309/ajg.0000000000000620
Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26:502–5. DOI: 10.1038/s41591-020-0817-4
Xing YH, Ni Y, Wu Q, Li WJ, Li GJ. Wang WD, et al. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019. J Microbiol Immunol Infect. 2020;53:473–80. DOI: 10.1016/j.jmii.2020.03.02
Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrier T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80.e8. DOI: 10.1016/j.cell.2020.02.052
Derikx LAAP, Lantinga MA, de Jong DJ, van Dop WA, Creemers RH, Römkens TEH, et al. Clinical outcomes of covid-19 in patients with inflammatory bowel disease: A Nationwide Cohort Study. J Crohns Colitis. 2021;15(4):529-539. DOI: 10.1093/ecco-jcc/jjaa215
Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrier T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80.e8. DOI: 10.1016/j.cell.2020.02.052
Rubin DT, Abreu MT, Rai V, Siegel CA. International organization for the study of inflammatory bowel disease. Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. Gastroenterology. 2020;159(1):6-13.e6. DOI: 10.1053/j.gastro.2020.04.002.
Khan N, Patel D, Xie D, Pernes T, Lewis J, Yang YX. Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study. Am J Gastroenterol. (2021) 116(4):808-810. doi: 10.14309/ajg.0000000000001012.
Rosenbaum JE, Ochoa KC, Hasan F, et al. Epidemiologic assessment of pediatric inflammatory bowel disease presentation in NYC during COVID-19. J Pediatr Gastroenterol Nutr. 2023;76(5):622-626. DOI: 10.1097/MPG.0000000000003740
Attauabi M, Poulsen A, Theede K, Pedersen N, Larsen L, Jess T et al. Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease-a danish prospective population-based Cohort Study. J Crohns Colitis. 2022;JJAC147. DOI: 10.1093/ecco-jcc/jjac147
Yaffe Y. Parental Worry About COVID- 19 in Preschool Children's Mothers During the Pandemic Waves: The Role of Maternal Negative Feelings and Parenting Styles. Matern Child Health J. 2023;27(4): 632-640. DOI: 10.1007/s10995-023-03626-3
Amiot A, Rahier JF, Baert F, et al. The Impact of COVID-19 on patients with IBD in a prospective European Cohort Study J Crohns Colitis. 2023;17(1):37-48. DOI: 10.1093/ecco-jcc/jjac091 [Accessed on J Crohns Colitis. 2023 Feb 18;.
Golla R, Vuyyuru S, Kante B, et al. Long-term gastrointestinal sequelae following COVID-19: A prospective follow-up cohort study. Clin Gastroenterol Hepatol. 2023; 21(3):789-796.e1. DOI: 10.1016/j.cgh.2022.10.015.
National Center for Health Statistics. Mental health: household pulse survey. Avaialable:https://www.cdc.gov/nchs/covid19/pulse/mental-health.htm (Accessed July 28, 2020)
Russell BS, Hutchison M, Tambling R, Tomkunas AJ, Horton AL. Initial Challenges of Caregiving During COVID-19: Caregiver Burden, Mental Health, and the Parent-Child Relationshipatry Hum Dev. 2020;51(5):671-682. DOI: 10.1007/s10578-020-01037-x
Goodsall TM, Han S, Bryant RV. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. J Gastroenterol Hepatol. 2021;36(6):1550-1555. DOI: 10.1111/jgh.15299
Reinsch S, Stallmach A, Grunert PC. The COVID-19 Pandemic: Fears and overprotection in pediatric patients with inflammatory bowel disease and their families. Pediatr Gastroenterol Hepatol Nutr. 2021;24(1):65-74. DOI: 10.5223/pghn.2021.24.1.65
Sun S, Yu K, Xie Z, Pan X. China empowers Internet hospital to fight against COVID-19. J Infect. 2020;81(1):e67-e68. DOI: 10.1016/j.jinf.2020.03.061
Mao R, Liang J, Wu K, Chen M. Responding to COVID-19: perspectives from the Chinese Society of Gastroenterology. Gastroenterology. 2020; 158(8):2024–2027. DOI: 10.1053/j.gastro.2020.03.046.
Pang L, Liu H, Liu Z, Tan J, Zhou LY, Qiu Y, Lin X, He J, Li X, Lin S, Ghosh S, Mao R, Chen M. Role of telemedicine in inflammatory bowel disease: Systematic review and meta-analysis of randomized controlled trials. J Med Internet Res. 2022;24(3):e28978. DOI: 10.2196/28978
Fritsch J, Garces L, Quintero MA, Pignac-Kobinger J, Santander AM, Fernández I, et al. Low-Fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2021;19(6):1189-1199.e30. DOI: 10.1016/j.cgh.2020.05.026
Xie Y, Zhou X. Income inequality in today's China. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(19):6928–33.
Zheng Y, Rodewald L, Yang J, Qin Y, Pang M, Feng L, et al. The landscape of vaccines in China: History, classification, supply, and price. BMC infectious Diseases. 2018;18(1):502
Lees CW, Regueiro M, Mahadevan U; International organization for the study of inflammatory bowel disease. Innovation in inflammatory bowel disease care during the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease. Gastroenterology. 2020;159(3):805-808.e1. DOI: 10.1053/j.gastro.2020.05.063